Cohance Lifesciences Ltd.

NSE: COHANCE | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
922.9000 23.60 (2.62%)
NSE Sep 05, 2025 15:31 PM
Volume: 83,546
 

announcement
Conference/Earnings Calls Alerts
922.90
2.62%
Conference Call with Suven Pharmaceuticals Management and Analysts to discuss the acquisition of Sapala Organics. Listen to the full transcript.
More from Cohance Lifesciences Ltd.
Recommended